{"nct_id":"NCT02536313","title":"Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination With or Without Ribavirin in Participants With Chronic Genotype 1 HCV Infection Previously Treated With a Direct Acting Antiviral Regimen","status":"COMPLETED","status_verified_date":"2017-08","start_date":"2015-07-29","start_date_type":"ACTUAL","primary_completion_date":"2016-03-28","primary_completion_date_type":"ACTUAL","completion_date":"2016-06-28","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GILD"]}